CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Peoria, Arizona, United States and 335 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Phoenix, Arizona, United States and 146 other locations
PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...
Phase 2
Chandler, Arizona, United States of America and 136 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Phoenix, Arizona, United States and 74 other locations
of a single inhaled dose of ASY202 in adults with stable asthma.Following screening, eligible participants will be enrolled and randomized t...
Phase 1
Glendale, Arizona, United States and 3 other locations
levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...
Phase 2
Tempe, Arizona, United States and 117 other locations
This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma ...
Phase 2
Chandler, Arizona, United States and 153 other locations
This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...
Phase 2
Sun City, Arizona, United States and 230 other locations
The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compa...
Phase 3
Paradise Valley, Arizona, United States and 66 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Paradise Valley, Arizona, United States and 394 other locations
Clinical trials
Research sites
Resources
Legal